tirzepatide good side effects Is Safe For Long-Term Use? A 2026 Clinical Perspective Tirzepatide vs. Semaglutide for Weight

Weight Management SURMOUNT trials demonstrated up to 22.5% Body-weight change over 72 weeks, approaching bariatric surgery outcomes

Across all treatment groups, 87% had a history of cardiovascular disease

NICE guidance (NG28) on type 2 diabetes management recognises GLP-1 receptor agonists as effective second- or third-line therapies, particularly for patients with obesity or those requiring additional glycaemic control

Inform medical staff of the exact dose you took and the time you took it

For CJC-1295 with DAC, timing is less critical due to the extended half-life, though many researchers prefer evening administration

Moses RG, Round E, Shentu Y et al (2016) A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control